BE838239A - Procede de preparation de produits pour administration orale - Google Patents

Procede de preparation de produits pour administration orale

Info

Publication number
BE838239A
BE838239A BE164070A BE164070A BE838239A BE 838239 A BE838239 A BE 838239A BE 164070 A BE164070 A BE 164070A BE 164070 A BE164070 A BE 164070A BE 838239 A BE838239 A BE 838239A
Authority
BE
Belgium
Prior art keywords
oral administration
preparing products
preparing
products
oral
Prior art date
Application number
BE164070A
Other languages
English (en)
Inventor
T Kobayashi
A Okada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE838239A publication Critical patent/BE838239A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE164070A 1975-09-29 1976-02-03 Procede de preparation de produits pour administration orale BE838239A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50117513A JPS5840529B2 (ja) 1975-09-29 1975-09-29 ケイコウヨウセイザイノセイホウ

Publications (1)

Publication Number Publication Date
BE838239A true BE838239A (fr) 1976-05-28

Family

ID=14713609

Family Applications (1)

Application Number Title Priority Date Filing Date
BE164070A BE838239A (fr) 1975-09-29 1976-02-03 Procede de preparation de produits pour administration orale

Country Status (11)

Country Link
US (1) US4101651A (fr)
JP (1) JPS5840529B2 (fr)
BE (1) BE838239A (fr)
CA (1) CA1069047A (fr)
DE (1) DE2604044C2 (fr)
ES (1) ES445014A1 (fr)
FR (1) FR2325388A1 (fr)
GB (1) GB1539076A (fr)
MX (1) MX4338E (fr)
NL (1) NL167325C (fr)
SE (1) SE418146B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54107515A (en) * 1978-02-08 1979-08-23 Fujisawa Pharmaceut Co Ltd Medicinal composition containing tiaramide or its acid addition salt, and their preparation
JPS5513239A (en) * 1978-07-14 1980-01-30 Fujisawa Pharmaceut Co Ltd Fine particulate drug composition
US4321253A (en) * 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
US4362730A (en) * 1980-08-25 1982-12-07 Heinrich Mack Nachf. Chem-Pharm. Fabrik Vincamine saccharinate and a pharmaceutical composition containing it dissolved therein
US4340582A (en) * 1981-01-15 1982-07-20 Abbott Laboratories Erythromycin base tablets
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
FR2532177A1 (fr) * 1982-08-30 1984-03-02 Being Well Products Inc Complement nutritionnel a zones de liberation determinees et son procede de fabrication
US4749575A (en) * 1983-10-03 1988-06-07 Bio-Dar Ltd. Microencapsulated medicament in sweet matrix
US4708867A (en) * 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
US5286489A (en) * 1985-08-26 1994-02-15 The Procter & Gamble Company Taste masking compositions
US4971791A (en) * 1985-08-26 1990-11-20 The Procter & Gamble Company Taste masking compositions
US4693896A (en) * 1985-10-07 1987-09-15 Fmc Corporation Ethylcellulose-coated, gastric-disintegrable aspirin tablet
US4786508A (en) * 1986-05-30 1988-11-22 Warner-Lambert Company Coated dosage forms
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
KR960011236B1 (ko) * 1987-05-08 1996-08-21 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 제약학적 조성물 및 고체 제형
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
US5082669A (en) * 1989-07-20 1992-01-21 Dainippon Pharmaceutical Co., Ltd. Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked
TW212139B (fr) * 1991-04-15 1993-09-01 Yamanouchi Pharma Co Ltd
EP1027036A2 (fr) * 1997-10-03 2000-08-16 ELAN CORPORATION, Plc Preparation au gout dissimule
ATE269069T1 (de) * 1998-04-29 2004-07-15 Sumitomo Pharma Orale zubereitung enthaltend einen biguanid und eine organische säure
JP4606582B2 (ja) * 1998-04-29 2011-01-05 大日本住友製薬株式会社 ビグアナイド系薬物の内服製剤
US6551617B1 (en) 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
ES2284643T3 (es) 2000-04-20 2007-11-16 Novartis Ag Composicion de revestimiento enmascarante del sabor.
US20030170310A1 (en) * 2002-03-08 2003-09-11 Hardeep Wadhwa Tasteless, directly compressible, fast-dissolving complexes and pharmaceutical formulations thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE575775A (fr) * 1958-02-18
US3242049A (en) * 1963-05-20 1966-03-22 Ncr Co Process for making enterically useful complex of spiramycin and product thereof
US3247065A (en) * 1963-10-14 1966-04-19 Hoffmann La Roche Free-flowing coated ascorbic acid
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
JPS5214234B2 (fr) * 1971-07-30 1977-04-20
JPS523342B2 (fr) * 1972-01-26 1977-01-27
US3879511A (en) * 1972-07-03 1975-04-22 Warner Lambert Co Tasteless methenamine mandelate in a stabilized vegetable oil suspension
BE791458A (fr) * 1972-07-31 1973-05-16 Merck & Co Inc Produit microencapsule

Also Published As

Publication number Publication date
NL167325C (nl) 1981-12-16
US4101651A (en) 1978-07-18
DE2604044C2 (de) 1982-12-09
NL167325B (nl) 1981-07-16
GB1539076A (en) 1979-01-24
MX4338E (es) 1982-04-01
SE7601096L (sv) 1977-03-30
ES445014A1 (es) 1977-08-01
CA1069047A (fr) 1980-01-01
FR2325388B1 (fr) 1980-06-06
JPS5241214A (en) 1977-03-30
NL7601069A (nl) 1977-03-31
DE2604044A1 (de) 1977-03-31
FR2325388A1 (fr) 1977-04-22
JPS5840529B2 (ja) 1983-09-06
SE418146B (sv) 1981-05-11

Similar Documents

Publication Publication Date Title
BE838239A (fr) Procede de preparation de produits pour administration orale
RO70769A (fr) Procede pour la preparation des derives de 2-phenyle-3-acylbenzothiophene
RO69296A (fr) Procede pour la preparation des derives quinazoliniques
RO70768A (fr) Procede pour la preparation des derives de 2-aryle-5-phenylbenzothiophene
RO72873A (fr) Procede pour la preparation des derives de 2-phenylindol
PT64912B (fr) Procede pour la preparation de derives de salicilanilide
BE842252A (fr) Procede radioisotopique pour le marquage de produits pharmaceutiques lyophileses
RO75110A (fr) Procede pour la preparation des derives de diphenyleamine
CH614203A5 (en) Process for the preparation of thioxanthone derivatives
BE815574A (fr) Procede de preparation d'amino-anthraquinones
FR2317251A1 (fr) Procede de preparation de produits ceramiques
FR2322862A1 (fr) Procede de preparation d'anilino-3 pyrazolones-5
BE821697A (fr) Procede de preparation d'un amino-benzene
BE818579A (fr) Procede de preparation de derives de propanolamine
RO76124A (fr) Procede pour la preparation des derives de 3-hydroxymethylene-4-chromanone
BE814100A (fr) Procede de preparation de 5-nitro-naphtoquinone-(1
BE815747A (fr) Procede de preparation d'amino-benzene-carboxamides
BE813722A (fr) Procede de preparation d'epsilon-aminocapronamide
BE806410A (fr) Procede de preparation d'alkylhydroxybenzenes et produits obtenus
PT64919B (en) Process for preparing prostaglandin derivatives with pharmaceutical effect
BE817725A (fr) Procede nouveau de preparation d'aza-1-hydroxy-2-benzanthrone
BE817598A (fr) Procede de preparation de 17 beta-oxalylsteroides
BE818796A (fr) Procede de preparation de l'alpha-ethynyl-benzhydrol
BE812669A (fr) Procede de preparation de medicaments anti-neoplasiques
BE823560A (fr) Procede de preparation de n-formyl-diindole-alcaloides et produits obtenus

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: MEIJI SEIKA KAISHA LTD

Effective date: 19960203